MAYRA MONTIJO: Open Payments
NPI 1659095735 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$307 in 16 payments from 6 companies in 2025. Trend: 2023 $458 · 2024 $829 · 2025 $307
Food & beverage: $307
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $133 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $45 |
| ABBVIE INC. | 2 | $45 |
| Exact Sciences Corporation | 2 | $35 |
| Lilly USA, LLC | 2 | $34 |
| Phadia US Inc. | 1 | $16 |
Products named: CAPLYTA, XIFAXAN, VRAYLAR, Cologuard Collection Kit, JARDIANCE, MOUNJARO, ImmunoCAP.
Industry payments across NV — which companies pay providers there.
